<DOC>
	<DOCNO>NCT02210065</DOCNO>
	<brief_summary>The goal clinical research study learn give cytotoxic T lymphocytes ( CTLs ) help control CMV reactivates ( becomes active ) patient receive allogeneic stem cell transplant . Researchers also want learn safety give CTLs patient stem cell transplant .</brief_summary>
	<brief_title>Autologous Cytomegalovirus ( CMV ) -Specific Cytotoxic T Cells Cytomegalovirus ( CMV ) Reactivation</brief_title>
	<detailed_description>The CTLs : Blood ( 34 tablespoon ) draw 1 time . The blood frozen store laboratory MD Anderson future use make CTLs . If CMV come back transplant , blood use create CTLs . To create CTLs , blood cell grown laboratory train kill CMV . If blood use make CTLs within 3 year , destroy . CTL Administration : If CMV become active stem cell transplant , receive CTLs needle vein 1-5 minute one time , within 72 hour CMV becomes active . Before receive CTLs , receive Benadryl ( diphenhydramine ) Tylenol ( acetaminophen ) mouth help reduce risk side effect . This do either hospital ( yet discharge transplant ) outpatient clinic ( discharge ) . Your vital sign monitor end infusion , 30 60 minute infusion . Your oxygen level measure pulse oximetry . For test , clothespin-shaped clip place finger least 30 minute . If outpatient , remain clinic least 1 hour CTL infusion . If CMV become active stem cell transplant , receive CTL infusion . Study Visits : If CMV become active stem cell transplant , receive CTL infusion follow-up care do per post-transplant standard care . If receive CTL infusion , tests/procedures list . Within 48 hour CTL infusion : - You physical exam . - Blood ( 6 tablespoon ) draw routine test check kidney liver function . Part blood draw use pregnancy test woman able become pregnant . To take part study , must pregnant . Once week 4 week , blood ( 4-8 tablespoon ) draw check level CMV infection body . This may do often , doctor think need . About 1 , 2 , 3 , 4 week , 3 , 6 , 12 month CTL infusion : - You physical exam . - Blood ( 4 tablespoon ) draw routine test check kidney liver function . Blood ( 4 tablespoon ) drawn test learn way CTLs work long last body . This blood drawn CTL infusion , 2 week , 4 week , 3 month , 6 month CTL infusion . If possible , blood need test collect blood draw routine test additional needle stick need . Follow-Up Visits : Once week 6 week , 3 , 6 , 9 , 12 month CTL infusion , check sign graft-versus-host disease ( GVHD ) every clinic visit . You tell GVHD time prepared transplant . Length Study : Your participation study end last follow-up visit 12 month CTL infusion . This investigational study . The use CTLs treat CMV infection FDA approve . At time , CTLs use treat infection research study . Up 105 patient take part study . All enrol MD Anderson .</detailed_description>
	<criteria>1 . STEP 1 : Within 30 day study entry : Patients history bone marrow disorder include hematological malignancy aplastic anemia , Myelodysplastic Syndrome ( MDS ) Myeloproliferative disorder ( MPD ) plan undergo allogeneic HSCT reduce intensity myeloablative conditioning regimen . 2 . Disease status must complete remission standard criterion Lymphoma Acute Leukemia patient . 3 . Patients Myelodysplastic Syndrome ( MDS ) Myeloproliferative Disorder ( MPD ) must &lt; 5 % blast bone marrow . 4 . Patients T Cell ALL must complete remission MRD negative ( ) flow cytometry molecular study . 5 . Patients &gt; /= 18 year age . 6 . Karnofsky great equal 80 % . 7 . CMV seropositive . 8 . Donor either match relate , match unrelated , mismatch unrelated , haploidentical . Cord blood recipient also eligible . 9 . Hgb great 10 g/L . 10 . Patient patient 's legal representative , parent ( ) guardian able provide write informed consent . 11 . Negative pregnancy test female patient childbearing potential . 12 . STEP 2 : Eligibility time generate infuse CMVspecific cytotoxic T cell ( adoptive immunotherapy ) : CMV reactivation define CMV DNAemia &gt; /= 137 copies/ml . 13 . Evidence neutrophil engraftment define absolute neutrophil count ( ANC ) &gt; 0.5 X 10^3/for 3 consecutive day . 14 . Clinical status allow taper steroid le 0.5 mg/kg/day prednisone equivalent . 15 . Negative pregnancy test female patient childbearing potential . 1 . STEP 1 : Within 30 day study entry : T cell leukemia lymphoma . 2 . CMV seronegative . 3 . Positive HIV , HBV , HCV , HTLV1 and/or HTLV2 . 4 . STEP 2 : Eligibility time generate infuse CMVspecific cytotoxic T cell ( adoptive immunotherapy ) : Documented CMV endorgan disease . 5 . Patients receive ATG , Campath within 28 day CMV reactivation . 6 . Patients uncontrolled infection . For bacterial infection , patient must receive definitive therapy sign progress infection 72 hour prior generate CTLs . For fungal infection patient must receive definitive systemic antifungal therapy sign progress infection 1 week prior generate CTLs . Progressing infection define hemodynamic instability attributable sepsis new symptom , worsen physical sign radiographic finding attributable infection . Persisting fever without sign symptom interpret progress infection . 7 . Patients receive donor lymphocyte infusion ( DLI ) within 28 day . 8 . Patients active acute GVHD grade IIIV . 9 . Active uncontrolled relapse malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Blood And Marrow Transplantation</keyword>
	<keyword>Hematological malignancy</keyword>
	<keyword>Cytotoxic T cell</keyword>
	<keyword>CTL</keyword>
	<keyword>Cytomegalovirus</keyword>
	<keyword>CMV</keyword>
	<keyword>Allogeneic hematopoietic stem cell transplantation</keyword>
	<keyword>HSCT</keyword>
</DOC>